Bulk Inquiry
PELI1/EGFR disruptor S62
- SL-9
- Soluble in DMSO and EtOH
- MF: C24H32N2O2S
- MW: 412.59
Description
PELI1/EGFR disruptor S62 is a potent disruptor of Pelino-1 (PELI1) and EGFR. S62 effectively repressed breast cancer metastasis as indicated by the reduced migration and invasion of MDA-MB-231 cells in vitro and in vivo. Also, S62 enhanced the sensitivity of EGFR tyrosine kinase inhibitors.
More Information
| Parent CAS No. | N.A. |
|---|---|
| Chemical Name | 4-(2-Decanamidophenylthio)-N-methylbenzamide |
| MFCD | N.A. |
| Short Description | PELI1/EGFR disruptor |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1128 | Erlotinib hydrochloride |
From $77.00 |
| 1393 | Gefitinib |
From $77.00 |
| 1395 | Lapatinib ditosylate |
From $88.00 |
| 1411 | Vandetanib |
From $55.00 |
| 1433 | CI 1033 |
From $66.00 |
| 1506 | WZ 4002 |
From $77.00 |
| 1526 | Neratinib |
From $88.00 |
| 1544 | BIBW 2992 |
From $55.00 |
| 1632 | OSI 420 |
From $99.00 |
| 1653 | AEE 788 |
From $88.00 |
| 1665 | Pelitinib |
From $99.00 |
| 1760 | EGFR Inhibitor [879127-07-8] |
From $132.00 |
| 1986 | AST 1306 tosylate |
From $99.00 |
| 2342 | AZD9291 |
From $104.50 |
| 2563 | AZD3759 |
From $93.50 |
| 2680 | EAI045 |
From $115.50 |
| 2920 | Poziotinib |
From $104.50 |
| 2955 | NSC 228155 |
From $82.50 |
| 3040 | Abivertinib |
From $104.50 |
| 3192 | EMI48 |
From $132.00 |
| 3232 | TAK-788 |
From $77.00 |
| 3235 | Dacomitinib |
From $66.00 |
| 3802 | TAS6417 |
From Inquiry |
| 3853 | BMS-599626 |
From Inquiry |
